When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SGIOF - Roche's Xofluza reduced risk of contracting influenza in late-stage study
Shionogi & Co Ltd
A Phase 3 clinical trial, BLOCKSTONE, evaluating the ability of Roche's (OTCQX:RHHBY) Xofluza (baloxavir marboxil) to prevent a healthy person from contracting influenza from an infected family member met the primary endpoint. The results were presented at the OPTIONS X congress in Singapore.
More news on: Roche Holding AG, Shionogi & Co., Ltd., Shionogi & Co., Ltd., Healthcare stocks news,